ASH 2025 Update | Myelofibrosis Treatment and Research Findings

Dr. Gabriela Hobbs discusses important new developments in myelofibrosis treatment from the American Society of Hematology annual meeting. Dr. Hobbs highlights emerging therapies, novel combination approaches, and encouraging trial results that are aimed at improving symptoms, spleen size, and blood counts in people with myelofibrosis. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the care of patients with myeloproliferative neoplasms (MPN), chronic myeloid leukemia, and leukemia. Dr. Hobbs serves as clinical director of the adult leukemia service at Massachusetts General Hospital. Learn more about Dr. Hobbs: https://www.massgeneral.org/doctors/1.... Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to offer trusted information to empower anyone impacted by cancer, through health equity, health literacy and shared decision-making. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/stay-upd...